Candida Parapsilosis homeopathic remedy recalled for manufacturing practice deviations
Washington Homeopathic Products is recalling Candida Parapsilosis homeopathic remedies distributed nationwide due to manufacturing practice deviations. The recall affects 134 bottles under lot numbers 22315 and 26502.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary recall by the manufacturer due to cGMP deviations. No illnesses or injuries are reported in the source. The rubric classifies voluntary precautionary recalls as Moderate (score 2).
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Candida Parapsilosis homeopathic remedies in multiple potencies (liquid pellets). The products, distributed in 134 glass amber bottles under lot numbers 22315 and 26502, were distributed nationwide in the United States.
The recall is due to current Good Manufacturing Practice (cGMP) deviations in the manufacturing process. The manufacturer initiated this voluntary recall on May 13, 2022. The FDA classified it as a Class II recall on June 10, 2022, and the recall was terminated on May 25, 2023.
The recalled product
- Product
- Candida Parapsilosis, Potency: 14X, 15X, 16X, 20X, 28X, 30X, 9C, 10C, 13C, 15C, 25C, 30C, 13X, 27X, 30X, Liquid Pellets, OTC, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Remedy
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 22315
- 26502
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01